Medicine and Dentistry
Patient
100%
Therapeutic Procedure
44%
Blood Clotting Factor 8 Inhibitor
33%
Drug Megadose
22%
Combination Therapy
22%
Immunoglobulin
22%
Deterioration
22%
Maintenance Drug Dose
22%
Diseases
11%
Prednisone
11%
Bethesda Unit
11%
INIS
patients
100%
doses
44%
therapy
22%
maintenance
22%
levels
11%
units
11%
reduction
11%
induction
11%
prednisone
11%
Immunology and Microbiology
Titer
33%
Factor VIII
33%
Drug Megadose
22%
Intravenous Immunoglobulin
22%
Maintenance Drug Dose
22%
Prednisone
11%
Reduction (Chemistry)
11%
Pharmacology, Toxicology and Pharmaceutical Science
Blood Clotting Factor 8 Inhibitor
33%
Maintenance Dose
22%
Immunoglobulin
22%
Deterioration
22%
Prospective Study
22%
Diseases
11%
Prednisone
11%
Neuroscience
Blood Clotting Factor 8
33%
Intravenous Immunoglobulin
22%
Prednisone
11%